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mediate increased permeability of the erythrocyte plasma membrane to various solutes (6–18).
The mechanism underlying the role of the RhopH complex in
PSAC activity remains poorly understood. How the components
of the RhopH complex are trafficked from the parasite out to the
erythrocyte membrane is also not known, although it has been
hypothesized that they may assume a soluble form or associate
with additional proteins that protect them as they traverse the
host-cell cytosol (9). Another theory suggests that they may cross
the cytosol via a series of membranous compartments created by
the parasite, known as the exomembrane system (19, 20). Highresolution structures of the RhopH complex in either membranebound or soluble forms would help to answer these open questions
and provide a much-needed structural framework to rationalize
the large body of seemingly contradictory phenotypic and biochemical data that surround this intriguing complex.
To address the question of how members of the RhopH
complex are delivered to the erythrocyte membrane, we sought
to investigate whether a soluble complex containing one or more
components of the RhopH complex exists in soluble parasite
lysate and determine its structure if it did. Unfortunately, the
extreme difficulty of producing properly folded and assembled P.
falciparum protein complexes via reconstitution or coexpression
in heterologous systems has thus far stymied efforts to obtain
Significance
Malaria parasites invade and replicate within human red blood
cells, which lack nuclei and have minimal metabolic activity. To
survive, the parasites create new pathways that alter the
permeability of the red blood cell membrane, allowing them to
import nutrients and export waste. Here, we present the native
structure of the three-membered RhopH protein complex,
which plays a key role in this process. We determined the
structure of this essential complex from a heterogeneous
mixture of proteins enriched directly from parasite cell lysate,
using a cryo-electron microscopy–enabled endogenous structural proteomics approach. The native structure of the RhopH
complex in a soluble, trafficking state helps elucidate the longstanding question of how parasite transmembrane proteins
are trafficked to the erythrocyte membrane.
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early half the world’s population is at risk for contracting
malaria. To keep the disease at bay, we rely heavily on
artemisinin-based therapies, limiting malaria’s impact to 200 million cases and half a million deaths each year (1). The recently
discovered de novo emergence of artemisinin-resistant malaria
parasites in Africa heightens the urgent need to define, and thus
target, molecular machineries essential for parasites’ survival in
human erythrocytes, thereby facilitating the development of new
therapeutics with novel modes of action (1–3). To survive inside
human red blood cells, the malaria parasite Plasmodium falciparum
deploys hundreds of effector proteins that extensively remodel the
normally quiescent host erythrocyte, building new infrastructure for
nutrient uptake, waste efflux, and immune evasion to support the
active growth and replication of the parasite (4, 5). Members of the
high-molecular mass rhoptry protein complex known as the RhopH
complex—comprising CLAG3, RhopH2, and RhopH3—have been
shown to play a key role in this process by directly or indirectly
contributing to the activity of the Plasmodium surface anion channel
(PSAC), a novel ion channel that appears at the cell surface in
malaria parasite–infected erythrocytes and has been shown to
PNAS 2021 Vol. 118 No. 35 e2100514118

Author contributions: C.-M.H. and Z.H.Z. designed research; C.-M.H. performed research;
D.E.G. and J.R.B. contributed new reagents/analytic tools; C.-M.H., J.J., M.L., and X.L. analyzed data; and C.-M.H. and Z.H.Z. wrote the paper.
The authors declare no competing interest.
This article is a PNAS Direct Submission.
This open access article is distributed under Creative Commons Attribution-NonCommercialNoDerivatives License 4.0 (CC BY-NC-ND).
1

To whom correspondence may be addressed. Email: chi-min.ho@columbia.edu or Hong.
Zhou@UCLA.edu.

This article contains supporting information online at https://www.pnas.org/lookup/suppl/
doi:10.1073/pnas.2100514118/-/DCSupplemental.
Published August 26, 2021.

https://doi.org/10.1073/pnas.2100514118 | 1 of 8

MICROBIOLOGY

The RhopH complex is implicated in malaria parasites’ ability to
invade and create new permeability pathways in host erythrocytes,
but its mechanisms remain poorly understood. Here, we enrich the
endogenous RhopH complex in a native soluble form, comprising
RhopH2, CLAG3.1, and RhopH3, directly from parasite cell lysates
and determine its atomic structure using cryo–electron microscopy
(cryo-EM), mass spectrometry, and the cryoID program. CLAG3.1 is
positioned between RhopH2 and RhopH3, which both share substantial binding interfaces with CLAG3.1 but make minimal contacts
with each other. The forces stabilizing individual subunits include 13
intramolecular disulfide bonds. Notably, CLAG3.1 residues 1210 to
1223, previously predicted to constitute a transmembrane helix, are
embedded within a helical bundle formed by residues 979 to 1289
near the C terminus of CLAG3.1. Buried in the core of the RhopH
complex and largely shielded from solvent, insertion of this putative
transmembrane helix into the erythrocyte membrane would likely
require a large conformational rearrangement. Given the unusually
high disulfide content of the complex, it is possible that such a
rearrangement could be initiated by the breakage of allosteric disulfide bonds, potentially triggered by interactions at the erythrocyte
membrane. This first direct observation of an exported Plasmodium
falciparum transmembrane protein—in a soluble, trafficking state
and with atomic details of buried putative membrane-insertion
helices—offers insights into the assembly and trafficking of RhopH
and other parasite-derived complexes to the erythrocyte membrane. Our study demonstrates the potential the endogenous structural proteomics approach holds for elucidating the molecular
mechanisms of hard-to-isolate complexes in their native,
functional forms.

BIOPHYSICS AND
COMPUTATIONAL BIOLOGY

Edited by Robert M. Stroud, University of California, San Francisco, CA, and approved June 4, 2021 (received for review January 13, 2021)

high-resolution structures of the RhopH complex. Furthermore,
the uncertainty about the exact composition of a putative soluble
RhopH complex precluded the use of a heterologous system to
recapitulate the complex. To address challenges like this, we recently established an endogenous structural proteomics approach
that combines the use of cryo–electron microscopy (cryo-EM), mass
spectrometry, and cryoID, a program we developed to identify
proteins in sub-4.0Å cryo-EM density maps, to identify and determine the structures of unknown protein complexes (Fig. 1) (21).
Here, we have used this approach to obtain a near-atomic resolution structure of the unmodified RhopH complex in a soluble state,
enriched directly from P. falciparum parasite lysate. The structure
explains the body of existing biochemical data, provides insights into
the dual roles of the RhopH complex in both invasion and creation
of new permeability pathways in host erythrocytes, and sheds light
on the long-standing question of how parasite transmembrane
proteins are trafficked to the erythrocyte membrane. The study also
demonstrates the power of the endogenous structural proteomics
approach to provide exciting insights into the molecular mechanisms of hard-to-isolate complexes from challenging native sources
where conventional structural biology approaches have failed.
Results
Identification and Structure Determination of Soluble RhopH Complex.
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Following an endogenous structural proteomics workflow (21)
(Fig. 1A), we used mass spectrometry to identify fractions of P.
falciparum parasite lysate that both looked promising by negative
stain EM and contained one or more components of the RhopH
complex (Fig. 1 B and C and Dataset S1). Analysis of a cryo-EM
dataset collected from one of these fractions in RELION (22) and
cryoSPARC (23) yielded numerous promising two-dimensional
(2D) class averages (Fig. 1 D and E and SI Appendix, Fig. 1).
We identified a subset of these class averages that gave rise to a
near-atomic resolution cryo-EM density map of a novel, asymmetric protein complex at an overall resolution of 3.7 Å after ab
initio reconstruction and nonuniform refinement in cryoSPARC
(Fig. 2 and SI Appendix, Fig. 1).

Following further focused classification and refinement in
RELION to improve local resolutions throughout the map, we
were able to use cryoID to successfully identify all three components of the complex as RhopH2, CLAG3.1, and RhopH3, the
three members of the RhopH complex (Fig. 2 B and E–G and SI
Appendix, Fig. 1 and Movies 1–3). Clear side-chain densities
throughout most of the map enabled us to build de novo atomic
models of the three components (Fig. 2B and SI Appendix, Fig.
2), revealing a tripartite protein complex containing a single copy
of each of the three proteins, with a total calculated mass of 435
kDa, assuming no posttranslational truncations.
Although the CLAG3.1 and CLAG3.2 isoforms share 96%
protein sequence identity, there is a known hypervariable region
(10) (HVR) (F1094 to G1142), where CLAG3.1 in NF54 parasites
includes an extra two amino acids (a.a.) (T1140 to H1141) that are
not found in CLAG3.2 in NF54 parasites. Fortunately, we had
strong density in this region that enabled us to definitively resolve
that the isoform in our map is CLAG3.1 (SI Appendix, Fig. 3),
consistent with previous findings that suggest CLAG3.1 is preferentially expressed in culture (24). The overall map quality was also
such that we were able to model the bulk of the complex’s visible
density, the main exception being a small auxiliary domain near the
C terminus of RhopH2, which at a lower density threshold value
(σ = 0.0355) accounts for ∼6.9% of our complex’s total volume (SI
Appendix, Fig. 4). Though the density here was of insufficient quality
to register residues, we were able to discern that the region mainly
comprises several twisted β-strands constituting a β-sheet–rich core.
CLAG3.1 forms the core of the complex and is situated between RhopH2 and RhopH3 (Fig. 2 A and B and Movie 4).
RhopH2 and RhopH3 both share substantial binding interfaces
with CLAG3.1 but make minimal contacts with each other
(Movie 4). Buried and exposed surface areas were calculated
using PDBePISA (25). Of the two, the CLAG3.1–RhopH3 interface is more extensive, accounting for a buried surface area of
5,416 Å2 (∼11 to 15% of the total exposed surface area of either
CLAG3.1 or RhopH3), compared with a buried surface area of
3,410 Å2 for the CLAG3.1–RhopH2 interface (∼7 to 7.5% of the

Fig. 1. Endogenous structural proteomics workflow using cryoID. (A) Depiction of the workflow. P. falciparum parasites and parasitophorous vacuoles were
saponin-released from P. falciparum–infected red blood cells, and the resulting parasite and vacuole pellets were lysed and fractionated using a sucrose
gradient. The fractions were evaluated by SDS-PAGE, mass spectrometry, and negative stain EM. Cryo-EM imaging and analysis of the selected fraction
yielded a 3.7-Å resolution cryo-EM density map. The proteins in the cryo-EM map were identified using cryoID and then modeled de novo, yielding the final
atomic resolution structure of the RhopH complex. (B) Silver-stained SDS-PAGE of the selected fraction of the lysate. Arrowheads denote bands consistent
with the molecular weights of the components of the RhopH complex. (C and D) Representative negative stain (C) and cryo-EM (D) micrographs of the
selected fraction. (Scale bars, 20 nm.) Arrowheads denote particles consistent with 2D class averages of the RhopH complex. (E) Representative 2D class
averages corresponding to multiple protein complexes present in the single dataset of cryo-EM micrographs. Class averages that ultimately gave rise to the
structure of the RhopH complex presented here are boxed in green. (Scale bar, 10 nm.)
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Fig. 2. Cryo-EM density map of the soluble RhopH complex. (A) Cryo-EM density map of the RhopH complex viewed from multiple angles, with RhopH2,
CLAG3.1, and RhopH3 colored in navy, gold, and green, respectively. Unmodeled regions are shown in gray. (B) Atomic model of the soluble RhopH complex,
colored as in A, with the query segments used for protein identification by cryoID colored in pink. (C and D) Local resolution evaluation of the soluble RhopH
complex map, calculated using Resmap (57), colored according to resolution, and displayed as a full surface (C) and central slice (D). (E–G) Detailed view of
each set of query sequences used for cryoID identification for RhopH2 (E), CLAG3.1 (F), and RhopH3 (G), shown with corresponding cryo-EM density (mesh).
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total exposed surface area of either CLAG3.1 or RhopH2). All
three protein components contain an unusually high abundance of
cysteines in their primary sequence (13, 10.5, and 15.6% in RhopH2,
CLAG3.1, and RhopH3, respectively), which is particularly striking
given the relatively low presence of cysteines in the P. falciparum
proteome (∼1.7%). Our CLAG3.1 structure contains three sets of
disulfide bonds, while RhopH2 and RhopH3 contain five sets of
disulfide bonds each (SI Appendix, Fig. 5).
RhopH3 Architecture Explains RhopH3 Truncation Phenotypes. RhopH3
is an 897 a.a. protein, whose visible structure can be divided into
three domains (Fig. 3): an elongated N-terminal domain arising
from RhopH3 exons 1 to 3 (corresponding to a.a. 1 to 378),
composed of a set of interleaved β-sheets flanked by α-helices; a
globular α-helix–rich “middle domain” from RhopH3 exons 4 to 6
(a.a. 379 to 675); and an extended C-terminal domain arising from
RhopH3 exon 7, characterized by a long loop-rich segment that
extends toward RhopH2 (Fig. 3C). The first N-terminal 25 residues

were not modeled due to disordered density, nor were residues after
a.a. 738, although scattered weak “pigtail” density can be observed
after a.a. 738 further extending into a cleft in the RhopH complex
between the major bodies of RhopH2 and RhopH3 (SI Appendix,
Fig. 4E). The N and C termini of the N-terminal and C-terminal
domains, respectively, are positioned adjacent to the RhopH2–
CLAG3.1 interface, unlike the middle domain, which is located on
the far side of CLAG3.1 (Fig. 3 A and C). This explains previous
studies suggesting that exons 1 to 3 and exon 7 help to form the
interaction between CLAG3 and RhopH2, while the RhopH3 exons
4 to 6 do not appear to play a role in CLAG3–RhopH2 binding but
rather are required for trafficking to the rhoptries (9, 12).
The aforementioned abundance of cysteines in the RhopH
complex plays an especially important role in the structural organization of RhopH3. Notwithstanding the unmodeled auxiliary
domain of RhopH2, RhopH3 is unique among the constituents of
the RhopH complex in possessing the only β-sheets within the
main complex; in contrast, RhopH2 and CLAG3.1 are dominated
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Fig. 3. Structural details of RhopH3. (A) RhopH3 (ribbon diagram) and RhopH2 and CLAG3.1 (space-filling surface diagram in different blue and orange,
respectively) showing the interfaces between RhopH3 and the other components of the RhopH complex. (B) Front and back views showing the arrangement
of RhopH3 domains. (C) Multiple views of the RhopH3 N-terminal, middle, and C-terminal domains, corresponding to RhopH3 exons 1 to 3, 4 to 6, and 7, and
colored mint, green, and forest, respectively.

by α-helices. Three sets of β-sheets present in RhopH3’s N-terminal
domain give rise to an interleaved β-sheet motif, largely facilitated
by a 20 residue–long continuous loop (a.a. 225 to 245) that contributes a single β-strand to all three sets of β-sheets, effectively
chaining the three β-sheets together (SI Appendix, Fig. 6). Notably,
this 20 residue continuous loop contains two cysteine residues,
Cys231 and Cys244, each of which participates in a disulfide bond
(with Cys157 [from an adjacent loop that also contributes β-strands
to the interleaved β-sheets] and Cys253 of RhopH3, respectively) in
a manner that could fix this structurally critical β-strand–containing
loop in place (SI Appendix, Figs. 5 and 6). We therefore speculate
that these cysteine residues are of vital importance to the proper
folding and assembly of RhopH3.
Structural Details of RhopH2. Of the three components of the
RhopH complex, RhopH2 is the least studied. We modeled 972
residues of the 1378 a.a. in RhopH2 and five disulfide bonds. Our
structure reveals that RhopH2 is an elongated globular protein
comprised primarily of α-helices and loops, although a small
unmodeled domain putatively extending from RhopH2’s C terminus is of sufficient resolution to see that it is rich in β-sheets.
Within the tripartite RhopH complex, RhopH2 forms the smaller
of two lobes and interfaces with CLAG3.1 solely through residues
385 to 830.
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Putative Transmembrane and Extracellular Elements of CLAG3.1 Are
Buried. The 1,209 residues of CLAG3.1 in our structure can also

be divided into three domains (Fig. 4A). Residues 52 to 675 form a
globular N-terminal domain that shares an interface with the
RhopH3 “middle domain” (Fig. 4). Residues 688 to 978 form a
squid-shaped “middle” domain, with the head sharing an interface
with RhopH2, while the legs wrap around the third CLAG3.1
domain—a helical bundle comprising residues 979 to 1289 (Fig. 4A).
CLAG3 has been demonstrated to modulate PSAC activity
(10, 26), and it has been postulated that CLAG3 may be a major
or sole component of the PSAC ion-conducting pore (10). Based on
membrane protein prediction software and helical wheel analysis,
CLAG3.2 residues 1203 to 1223 were hypothesized to constitute a
transmembrane domain, with F1200 to S1217 predicted to form an
amphipathic helix that oligomerizes with the same helix from
multiple CLAG3.2 monomers to form the transmembrane pore of
PSAC, similar to oligomeric pore-forming bacterial toxins (11, 27).
However, recent CLAG3.1/3.2 knockdown and complete knockout
4 of 8 | PNAS
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studies suggest that CLAG3 isoforms cannot be the sole component
of the PSAC transmembrane pore (8, 28).
In our structure, CLAG3.1 residues 1210 to 1223, previously
predicted to constitute a transmembrane helix, are embedded in
the middle of the helical bundle formed by residues 979 to 1289,
near the C terminus of CLAG3.1 (Fig. 4 B–G). As such, they are
buried in the core of the RhopH complex and mostly shielded
from the solvent by the helical bundle (Fig. 4 B–G). Inspection of
the residues corresponding to the putative transmembrane helix
(a.a. 1200 to 1223) in the structure reveals that F1200 to S1217 does
form an α-helix, but it is not amphipathic across the entire length of
that sequence as was previously predicted (Fig. 4G) (11). The amphipathic portion of the helix (N1199 to Y1210) spans three turns
(11 residues) and measures ∼15 Å in length (Fig. 4G), 4 to 7 residues shorter than the typical minimum length of a transmembrane
helix. As typical biological membranes range from 20 to 40 Å in
thickness, it is possible that the predicted transmembrane helix either fails to reach all the way across the membrane or may have to
form a coiled-coil interaction with another helix in order to do so.
The polar face of the N-terminal 3 turns of this helix, comprising
residues N1199, E1203, N1206, and possibly Y1210, are solvent
exposed and contribute to the outward, solvent-facing surface of the
helical bundle (Movies 5 and 6). All other residues in the N1199 to
A1222 helix are buried.
Residues Y1093 to G1142 constitute the HVR previously shown
to be exposed on the surface of infected red blood cells in
membrane-associated CLAG3.1/3.2 (10) (SI Appendix, Fig. 3). In
our structure, this region forms the ends of two helices in the helical
bundle, as well as the long loop between them, which extends up
from the middle of the CLAG3.1 C-terminal helical bundle through
the CLAG3.1–RhopH3 N-terminal domain interface (Fig. 4 and
Movie 7). There are 20 residues in the middle of the loop that are
unstructured in our density map. Intriguingly, most of the HVR that
we can see in our structure is buried deep in the middle of the
helical bundle, shielded from solvent by both the CLAG3.1 helical
bundle and the RhopH3 N-terminal domain (Fig. 4 B–G and
Movies 5–7).
Discussion
High-resolution structures provide invaluable frameworks for
interpreting the wealth of biochemical and genetic data surrounding
protein complexes implicated in the pathogenesis of malaria parasites (29). Unfortunately, structural studies in malaria have been
notoriously difficult (30). Many P. falciparum proteins are extremely
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challenging to overexpress recombinantly, with multiprotein complexes presenting a particular challenge due to the difficulty of recapitulating proper folding and assembly via reconstitution or
coexpression in heterologous systems. Using our endogenous structural proteomics approach (21), we circumvented these obstacles to
determine a near-atomic structure of the native RhopH complex,
enriched directly from parasite-infected red blood cells. A recent
paper (31) reported an atomic structure of the RhopH complex.
Their structure was obtained from proteins purified using engineered tags. The two structures are largely consistent with each
other, but our native complex contains a different CLAG isoform
(CLAG3.1 versus CLAG 3.2), and we were able to model an additional 459 a.a. residues in the RhopH2 subunit of the native complex.
This discovery of a hypothesized—but hitherto unobserved—soluble
state of the native RhopH complex is a direct observation of an
exported P. falciparum transmembrane protein in its soluble, trafficking state. This represents a major step forward in addressing the
long-standing question of how parasite effectors, many of which are
integral membrane proteins (4, 5), are trafficked to their final site of
action in the erythrocyte membrane.
The structure provides exciting insights into how trafficking
works, revealing that previously predicted transmembrane and
extracellular elements are buried in the middle of the complex,
likely to protect these elements from the aqueous cytosolic environment during transit. Taken into account with all the data we
have thus far (Movie 8) (8–19, 24, 26, 28, 32, 33), this discovery
seems to point toward a model in which CLAG3, RhopH2, and
RhopH3 associate early in the secretory pathway (8–10, 12), dissociating only for translocation across the parasitophorous vacuole
membrane through PTEX (9, 34) and reforming the soluble complex state in the erythrocyte cytosol to complete the journey out to
the erythrocyte surface (9). This suggests that the RhopH complex
shares the ability of pathogenic pore-forming proteins to transition

from a soluble form for traversing aqueous cytosolic environments
to an integral transmembrane protein form upon arriving at its
target membrane (27, 35, 36) and that such transitions may represent a general strategy employed by the parasite to deliver protein
complexes to the erythrocyte membrane.
The ability to transition from a soluble form for traversing
aqueous cytosolic or extracellular environments to an integral
transmembrane protein form upon arriving at the target membrane is the unifying key feature shared by pore-forming proteins
in biological systems ranging from bacteria to vertebrates (36).
As such, there is an argument for considering the RhopH complex to be a pore-forming protein complex. While the use of
pore-forming proteins to unrestrictively permeabilize and lyse
host-cell membranes during invasion and egress is a well-studied
strategy commonly used by a wide variety of pathogens, including
P. falciparum itself (27, 36–38), the use of pore-forming proteins
to selectively alter host-cell permeability to particular ions or
solutes without destroying the membrane is less common and
less well understood. This strategy is rare in bacteria but essential
for the function of several enveloped viruses, including influenza
and HIV (36). In this respect, P. falciparum’s use of the RhopH/
PSAC complex to modulate host erythrocyte membrane permeability for nutrient acquisition is more similar to how viruses
use viroporins to establish ion-specific permeability across hostcell membranes, making the RhopH complex distinct from the
more common use of pore-forming proteins by malaria parasites
to perforate host-cell membranes during invasion and egress
(38). Similar to most viroporins (35), the vast majority of the
RhopH complex is located intracellularly, with only the HVR
exposed on the erythrocyte membrane surface (10). The mechanisms underlying viroporins’ transitions from soluble to membrane bound, often triggered by a change in pH or interaction
with a lipid or protein in the target membrane, may hold hints
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Fig. 4. Structural details of CLAG3.1. (A) Atomic model of CLAG3.1 shown as a ribbon. (B and C) Detailed views of the CLAG3.1 helical bundle and HVR from
the top (B) and side (C). One helix in front is removed for clarity in C. The helical bundle is shown in cornflower blue and the HVR in cyan. For CLAG3.1 residues
N1197 to A1222, hydrophobic residues, charged and polar residues, and A1211 are shown in yellow, pink, and green, respectively. The CLAG3.1-specific T1140
to H1141 residues are shown in orange. (D) View rotated 90° from C, better showing the HVR. (E and F) Cutaway space filling top (E) and side (F) views of the
helical bundle and HVR, except residues N1197 to A1222, which are displayed in ribbon diagram. (G) Detailed view of CLAG3.1 N1197 to A1222.
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about the possible mechanism by which elements of CLAG3.1 are
inserted into the erythrocyte membrane. Given the unusual abundance of both cysteines and disulfide bonds in the RhopH complex,
we speculated that the large conformational change the RhopH
complex would need to undergo at the membrane to expose and
insert the putative transmembrane and extracellular elements into the
erythrocyte membrane might be triggered or regulated by allosteric
disulfide bonds.
First discovered more than a decade ago, the formation and
breaking of allosteric disulfide bonds have been firmly established as a strategy used in a wide range of biological systems for
regulating and modulating protein structure and function (39,
40). Indeed, when we examined the 13 disulfide bonds in our
structure, we found three that exhibited the well-defined strained
geometry that has been found to be the hallmark of all allosteric
disulfide bonds characterized thus far (SI Appendix, Table S1)
(39)—one in RhopH2, and two in RhopH3 (SI Appendix, Fig. 5).
As such, it is possible that these bonds may break or be cleaved
upon interaction with the erythrocyte membrane, triggering a
conformation change that extrudes the putative transmembrane and
extracellular elements from the middle of the complex and drives
them through membrane. While no parasite-derived protein disulfide isomerases (PDIs) have been identified in the P. falciparum
exportome, human erythrocytes do carry active PDIs in the plasma
membrane (41, 42), which could cleave the allosteric disulfides and
trigger the conformational change upon coming in contact with the
RhopH complex at the membrane. Indeed, previous studies have
shown that several human PDI inhibitors appear to exhibit anti–P.
falciparum activity, although their IC50 values vary (43). Alternatively, changes in redox potential in the cytosol could trigger the
breakage of the disulfide bonds to effect the massive conformational changes needed to expose and bring the helical bundle of
CLAG3 to interact with red blood cell membrane (Fig. 5 B and C).
Although surface-exposed membrane proteins with essential
functions in pathogenesis are often popular targets for drug development, these proteins have thus far proven to be difficult targets
for drug and vaccine development in P. falciparum, due to various
mechanisms the parasite employs to evade immune detection. If the
use of a soluble form is a general strategy employed by the parasite
to deliver proteins to the erythrocyte membrane, high-resolution
structures of the soluble trafficking forms of these essential membrane protein complexes present an opportunity to approach development of therapies from a new angle, focused on blocking

assembly or trafficking of complexes before they have a chance to
insert into the erythrocyte membrane. As such, the approach presented here for overcoming the barriers to high-resolution structural
studies in malaria parasites opens the door for developing new antimalarial therapies with novel modes of action and can also be applied to hard-to-isolate complexes in other biological systems to
answer long-standing questions.
Materials and Methods
Parasite Culture. P. falciparum cultures were prepared as described previously
(21, 29). Erythrocytes were then lysed with 0.0125% saponin (Sigma, sapogenin content ≥ 10%) in cold phosphate-buffered saline (PBS) with an EDTA-free
protease inhibitor mixture (Roche or Pierce). The released P. falciparum parasites were then washed in cold PBS with EDTA-free protease inhibitor mixture. The washed cell pellets were flash frozen in liquid nitrogen and stored
at −80 °C.
Sucrose Gradient Fractionation P. falciparum Parasite Lysate and Subsequent
Evaluation of Fractions Using Negative Stain EM. Frozen parasite pellets were
resuspended in lysis buffer (25mM Hepes pH7.4, 150mM KCl, 10mM MgCl2,
10% glycerol) and lysed using a glass Dounce tissue homogenizer. The soluble lysates were separated from the membrane fraction by centrifuging at
100,000 g for 1 h and then fractionated on a sucrose gradient as previously
described (21). The resulting fractions were evaluated for the presence and relative abundance of proteins of interest as described previously (21). Briefly,
fractions were assessed for the abundance of potential particles of interest based
on silver-stained sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE), tryptic digest liquid chromatography–mass spectrometry, and negative stain EM. The conventional approach of using gel filtration chromatography to assess sample quality was eschewed in favor of using negative stain EM to
directly visualize and evaluate the abundance of intact particles giving rise to
promising 2D class averages with distinct features. As such, small datasets of
∼100,000 particles were collected for each fraction, and 2D class averages generated in RELION (22, 44) were used to identify fractions containing promising
particles (Fig. 1E).
Mass Spectrometry. Mass spectrometry was performed as previously described
(21). The proteomics data will be deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the MassIVE partner
repository.
Cryo-EM. Cryo-EM grids of the selected fraction of parasite lysate were
prepared and imaged as described previously (21), yielding a final dataset
consisting of a total of 19,449 movies.

Fig. 5. Model of CLAG3.1 putative transmembrane domain and HVR insertion into the erythrocyte membrane. (A–C) Schematic illustrating a model for how
a conformational change in the RhopH complex may drive insertion of the extracellular and putative transmembrane elements into the red blood cell
plasma membrane.
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1) GLGYGYYGGLGYYGGGLYYYLLXYYG;
2) LLGGPPGGXGYLYLLGLGLGYYYXLYLL-GXGGYYYXXY.
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Using this set of query sequences, cryoID identified two candidates for the
protein in this region of the density map from a candidate pool consisting of
the 1,170 proteins identified in this sucrose gradient fraction by mass spectrometry (SI Appendix, Table S2). The two candidates, CLAG3.1 and CLAG3.2
from P. falciparum (O77309/ O77310), share 96% protein sequence identity. We
confirmed the identification by manually building a de novo atomic model into
the rest of the map (Fig. 2B). Focused classification and refinement were used to
improve the local resolution around the region corresponding to residues
1110 to 1150, one of the few segments in which CLAG3.1 and CLAG3.2 differ
in sequence. The improved resolution was sufficient for us to confidently
determine that the sequence in this region matches CLAG3.1 rather than
CLAG3.2 based on the presence of two residues, T1140 and H1141, which are
found in CLAG3.1 but not CLAG3.2, confirming that the protein in the
complex is CLAG3.1 (SI Appendix, Fig. 3).
We completed a backbone trace of the remaining regions of the density
map that did not correspond to CLAG3.1, which allowed us to determine that
there were likely two additional, distinct polypeptide chains represented in
the density map. We then used Get_queries to generate queries from these
two remaining regions of the density map, yielding two additional sets of
queries (Fig. 2 F and G). We manually inspected the query models, correcting
residues incorrectly assigned by Get_queries and extending the queries on
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1,170 proteins identified in this sucrose gradient fraction by mass spectrometry,
to be RhopH2 (Query Set 2) and RhopH3 (Query Set 3) from P. falciparum
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